Hetero Labs is recalling 5,424 bottles of Fenofibrate (145 mg), a medication used to lower cholesterol and triglycerides. The recall was initiated because a different medication, a Valacyclovir tablet (500 mg) used to treat viral infections, was found inside a bottle of Fenofibrate. These affected bottles were manufactured for Camber Pharmaceuticals and distributed to Indiana and Louisiana. Consumers should check their prescription bottles immediately to ensure they contain the correct medication.
Taking an incorrect medication like Valacyclovir instead of Fenofibrate could lead to ineffective treatment of your condition or unintended side effects from the foreign drug. This co-mingling occurred during the packaging process, posing a risk that patients may accidentally ingest the wrong medicine.
Drug recall remedy for co-mingled tablets
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.